Groundbreaking study reveals most effective adjunctive drug for Parkinson’s disease Post author: Post published:October 23, 2023 Post category:uncategorized The efficacy, tolerability, and safety of various anti-Parkinson’s drugs. You Might Also Like Allergies linked to heightened risk of long COVID, new review suggests November 9, 2023 Early lung cancer diagnosis improved with ctDNA methylation biomarkers February 25, 2025 New study pinpoints key markers for Long COVID diagnosis February 18, 2024